Feb. 19, 2025 — New research focuses on diagnostic delays experienced by people with epilepsy, a neurological disorder characterized by unpredictable seizures that affects over 3 million people ...

When you hear the word epilepsy, what comes to mind? For many, it rsquo;s a vague image of someone having a seizure ndash; ...

As global populations age, neurological disorders such as Alzheimer's, Parkinson's, and epilepsy become more prevalent.

“The addition of these five esteemed scientists to our SAB reflects our deepening clinical focus on epilepsy. Together with our current SAB members, their expertise will be invaluable as we ...

These include a Phase II trial (NCT06419608) in major depressive disorder (MDD), focal epilepsy, and generalised epilepsy. Topline results from the MDD study are expected in the second half of ...

NeuroPace, Inc., a medical device company dedicated to improving the lives of those with epilepsy, announced that its management will present at the Leerink Partners 2025 Global Healthcare ...

The company particularly targets drug-resistant epilepsy in children as the lead indication, but other forms of metabolic and neurological conditions are also expected to be amenable to ketone ...

The Diplomat Twitter Review: 10 tweets to read before watching John Abraham and Sadia Khateeb starrer political thriller Dolly Parton Makes Her First Public Appearance Amid Demise of Her Husband ...

Epilepsy in children is treatable, with medicines controlling seizures in most cases, says Dr. Pradnya Gadgil. Early diagnosis and adherence to treatments are crucial. Epilepsy surgery and special ...